Literature DB >> 26446100

[Annual report 2013 of the German Cardiac Pacemaker And Defibrillator Register--Part 2: implantable cardioverter-defibrillators. Pacemaker and AQUA Institute for Applied Quality Improvement and Research in Health Care GmbH workgroup].

A Markewitz1.   

Abstract

Mesh：

Year:  2015        PMID： 26446100     DOI： 10.1007/s00399-015-0398-y

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN： 0938-7412


× No keyword cloud information.
  8 in total

1.  Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality.

Authors:  Johannes B van Rees; C Jan Willem Borleffs; Mihály K de Bie; Theo Stijnen; Lieselot van Erven; Jeroen J Bax; Martin J Schalij
Journal:  J Am Coll Cardiol       Date:  2011-02-01       Impact factor: 24.094

2.  Here we go again--another failure of postmarketing device surveillance.

Authors:  Robert G Hauser
Journal:  N Engl J Med       Date:  2012-02-14       Impact factor: 91.245

3.  Clinical predictors of Fidelis lead failure: report from the Canadian Heart Rhythm Society Device Committee.

Authors:  David H Birnie; Ratika Parkash; Derek V Exner; Vidal Essebag; Jeffrey S Healey; Atul Verma; Benoit Coutu; Teresa Kus; Iqwal Mangat; Felix Ayala-Paredes; Pablo Nery; George Wells; Andrew D Krahn
Journal:  Circulation       Date:  2012-02-06       Impact factor: 29.690

4.  Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE).

Authors:  Jeff S Healey; Stefan H Hohnloser; Michael Glikson; Jorg Neuzner; Phillipe Mabo; Xavier Vinolas; Josef Kautzner; Gilles O'Hara; Lieselot VanErven; Fredrik Gadler; Janice Pogue; Ursula Appl; Jim Gilkerson; Thierry Pochet; Kenneth M Stein; Bela Merkely; Susan Chrolavicius; Brandi Meeks; Csaba Foldesi; Bernard Thibault; Stuart J Connolly
Journal:  Lancet       Date:  2015-02-23       Impact factor: 79.321

5.  Role of defibrillation threshold testing in the contemporary defibrillator patient population.

Authors:  Annina S Vischer; Christian Sticherling; Michael S Kühne; Stefan Osswald; Beat A Schaer
Journal:  J Cardiovasc Electrophysiol       Date:  2012-12-04

6.  Patient, physician, and procedural factors influencing the use of defibrillation testing during initial implantable cardioverter defibrillator insertion: findings from the NCDR®.

Authors:  Andrea M Russo; Yongfei Wang; Sana M Al-Khatib; Jeptha P Curtis; Rachel Lampert
Journal:  Pacing Clin Electrophysiol       Date:  2013-08-26       Impact factor: 1.976

7.  No benefit of a dual coil over a single coil ICD lead: evidence from the Sudden Cardiac Death in Heart Failure Trial.

Authors:  Pierre S Aoukar; Jeanne E Poole; George W Johnson; Jill Anderson; Anne S Hellkamp; Daniel B Mark; Kerry L Lee; Gust H Bardy
Journal:  Heart Rhythm       Date:  2013-04-04       Impact factor: 6.343

8.  Intra-operative defibrillation testing and clinical shock efficacy in patients with implantable cardioverter-defibrillators: the NORDIC ICD randomized clinical trial.

Authors:  Dietmar Bänsch; Hendrik Bonnemeier; Johan Brandt; Frank Bode; Jesper Hastrup Svendsen; Miloš Táborský; Stefan Kuster; Carina Blomström-Lundqvist; Angelika Felk; Tino Hauser; Anna Suling; Karl Wegscheider
Journal:  Eur Heart J       Date:  2015-06-25       Impact factor: 29.983
  8 in total
  5 in total

1.  Reduction of inappropriate ICD therapies in patients with primary prevention of sudden cardiac death: DECREASE study.

Authors:  Jörg Otto Schwab; Hendrik Bonnemeier; Thomas Kleemann; Johannes Brachmann; Sven Fischer; Frank Birkenhauer; Frank Eberhardt
Journal:  Clin Res Cardiol       Date:  2015-05-23       Impact factor: 5.460

2.  Application of the Bogossian formula for evaluation of the QT interval in pacemaker patients with stimulated left bundle branch block.

Authors:  K F Weipert; H Bogossian; P Conzen; G Frommeyer; C Gemein; I Helmig; R Chasan; L Eckardt; M Seyfarth; B Lemke; M Zarse; C W Hamm; J Schmitt; D Erkapic
Journal:  Clin Res Cardiol       Date:  2018-05-11       Impact factor: 5.460

3.  Mycobacterial lipoarabinomannans modulate cytokine production in human T helper cells by interfering with raft/microdomain signalling.

Authors:  A K Shabaana; K Kulangara; I Semac; Y Parel; S Ilangumaran; K Dharmalingam; C Chizzolini; D C Hoessli
Journal:  Cell Mol Life Sci       Date:  2005-01       Impact factor: 9.261

4.  [In Germany too many ICD implantations are performed: pro].

Authors:  D Böcker
Journal:  Herz       Date:  2016-03       Impact factor: 1.443

5.  Pulsed electron avalanche knife (PEAK) PlasmaBlade™ in pacemaker and defibrillator procedures.

Authors:  Elif Kaya; Matthias Totzeck; Tienush Rassaf
Journal:  Eur J Med Res       Date:  2017-11-21       Impact factor: 2.175
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.